Board of Directors Mike Humphrey Non-executive Chairman Effective date of current Term of office Current external 2 letter of appointment appointments 3 years, 3 months notice 24 March 2015 None Re-election to Board Age: 64 Committee memberships Annually at AGM 1 Nomination chair and Independent: N A Experience Remuneration Tenure: 4 years Formerly 40 years at Croda plc including 13 years as CEO Alan Aubrey Chief Executive Officer Effective date of current Term of office Current external 2 letter of appointment appointments Permanent, 6 months notice 20 January 2005 Non-executive Chairman Re-election to Board Proactis Holdings plc Age: 54 Annually at AGM Committee memberships Independent: No Experience None Tenure: 11 years Founder of Techtran Group, 7 years as partner at KPMG, FCA 20 Years Mike Townend Chief Investment Officer Effective date of current Term of office and Donaldson, Lufkin and letter of appointment Jenrette Permanent, 6 months notice 5 March 2007 Current external Re-election to Board 2 appointments Age: 53 Annually at AGM None Independent: No Experience Committee memberships 17 years equity capital Tenure: 9 years markets experience at None Lehman Brothers Greg Smith Chief Financial Officer Effective date of current Term of office Current external 2 letter of appointment appointments Permanent, 6 months notice 2 June 2011 None Re-election to Board Age: 37 Annually at AGM Committee memberships None Independent: No Experience Tenure: 4 years KPMG background, FCA 10 years David Baynes Chief Operating Officer Effective date of current Term of office Current external 2 letter of appointment appointments Permanent, 6 months notice 20 March 2014 None Re-election to Board Age: 52 Committee memberships Annually at AGM Independent: No None Experience Tenure: 2 years 10 years as CEO at Fusion IP plc, previous experience taking companies from start-up to full listing on the London Stock Exchange 48 IP Group plc Annual Report and Accounts for the year ended 31 December 2015 24609-04 Proof 9 5 April 2016 8:02 PM Our Governance Overview Do Dou ug g L Li iv five er rs si idg dge e, CB CBE E N Non on- -e ex xe ec cu ut tiiv five e Di Dir re ec ct tor or Effective date of current Term of office Current external letter of appointment: appointments 3 years, 3 months notice 20 March 2014 Chairman of Surgical Re-election to Board Innovations plc Age: 79 Annually at AGM Committee memberships Independent: Yes Experience Nomination, Audit and Tenure: 2 years 10 years as Chairman at Remuneration Fusion IP plc, 20 years at British Steel Jonathan Brooks Non-executive Director Effective date of current Term of office Current external letter of appointment appointments 3 years, 3 months notice 31 August 2011 Aveva Group plc Re-election to Board Age: 60 Committee memberships Annually at AGM Nomination, Audit chair Independent: Yes Experience and Remuneration chair Tenure: 3 years Formerly CFO ARM Holdings plc, 20 years technology sector experience, FCMA Professor Lynn Gladden, CBE Non-executive Director Effective date of current Term of office Engineering letter of appointment 3 years, 3 months notice Current external 26 March 2014 appointments Re-election to Board Age: 54 The British Land Company Annually at AGM PLC Independent: Yes Experience Committee memberships Tenure: 1 years Fellow of the Royal Nomination, Audit and Society, Royal Academy of Remuneration Engineering, Institution of Chemical Engineers, Royal Society of Chemistry and Institute of Physics, Shell Professor of Chemical Dr Elaine Sullivan Non-executive Director Current external Effective date of current Term of office appointments letter of appointment 3 years, 3 months notice 30 July 2015 Supervisory Board of Evotec Re-election to Board AG Age: 55 Annually at AGM Committee memberships Independent: Yes Experience Nomination, Audit and Tenure: Less than 1 year 25 years pharmaceutical Remuneration industry experience, senior management teams of Eli Lilly and Astra Zeneca, currently CEO of Carrick Therapeutics 1.
Mr Humphrey was considered by the Board to be independent on appointment.
Excludes appointments to Group portfolio company boards.
